Ho CYS - Search Results

1

Rapid Breakpoint Mapping of a Novel Germline PALB2 Duplication by PCR-Free Long-Read Sequencing for Interpretation of Its Pathogenicity.

Kwong A, Au CH, Shin VY, Ho DN, Wong EYL, Ho CYS, Chung Y, Chan TL, Ma ESK. Kwong A, et al. Among authors: ho cys. JCO Precis Oncol. 2021 Nov;5:1044-1047. doi: 10.1200/PO.20.00454. JCO Precis Oncol. 2021. PMID: 34994627 No abstract available.

2

Germline Mutation in 1338 BRCA-Negative Chinese Hereditary Breast and/or Ovarian Cancer Patients: Clinical Testing with a Multigene Test Panel.

Kwong A, Shin VY, Chen J, Cheuk IWY, Ho CYS, Au CH, Chan KKL, Ngan HYS, Chan TL, Ford JM, Ma ESK. Kwong A, et al. Among authors: ho cys. J Mol Diagn. 2020 Apr;22(4):544-554. doi: 10.1016/j.jmoldx.2020.01.013. Epub 2020 Feb 15. J Mol Diagn. 2020. PMID: 32068069 Free article.

3

Somatic mutation profiling in BRCA-negative breast and ovarian cancer patients by multigene panel sequencing.

Kwong A, Cheuk IW, Shin VY, Ho CY, Au CH, Ho DN, Wong EY, Yu SW, Chen J, Chan KK, Ngan HY, Chan TL, Ma ES. Kwong A, et al. Am J Cancer Res. 2020 Sep 1;10(9):2919-2932. eCollection 2020. Am J Cancer Res. 2020. PMID: 33042626 Free PMC article.

4

Mutation screening of germline TP53 mutations in high-risk Chinese breast cancer patients.

Kwong A, Shin VY, Ho CYS, Au CH, Slavin TP, Weitzel JN, Chan TL, Ma ESK. Kwong A, et al. Among authors: ho cys. BMC Cancer. 2020 Nov 2;20(1):1053. doi: 10.1186/s12885-020-07476-y. BMC Cancer. 2020. PMID: 33138793 Free PMC article.

5

A Case Report of Germline Compound Heterozygous Mutations in the BRCA1 Gene of an Ovarian and Breast Cancer Patient.

Kwong A, Ho CYS, Shin VY, Au CH, Chan TL, Ma ESK. Kwong A, et al. Among authors: ho cys. Int J Mol Sci. 2021 Jan 17;22(2):889. doi: 10.3390/ijms22020889. Int J Mol Sci. 2021. PMID: 33477375 Free PMC article.

6

Germline PALB2 Mutation in High-Risk Chinese Breast and/or Ovarian Cancer Patients.

Kwong A, Shin VY, Ho CYS, Khalid A, Au CH, Chan KKL, Ngan HYS, Chan TL, Ma ESK. Kwong A, et al. Among authors: ho cys. Cancers (Basel). 2021 Aug 20;13(16):4195. doi: 10.3390/cancers13164195. Cancers (Basel). 2021. PMID: 34439348 Free PMC article.

7

Effect on Germline Mutation Rate in a High-Risk Chinese Breast Cancer Cohort after Compliance with The National Comprehensive Cancer Network (NCCN) 2023 v.1 Testing Criteria.

Kwong A, Ho CYS, Luk WP, Fung LH, Au CH, Ma ESK. Kwong A, et al. Among authors: ho cys. Cancers (Basel). 2023 May 6;15(9):2635. doi: 10.3390/cancers15092635. Cancers (Basel). 2023. PMID: 37174101 Free PMC article.

8

Double Heterozygosity for Germline Mutations in Chinese Breast Cancer Patients.

Kwong A, Ho CYS, Au CH, Ma ESK. Kwong A, et al. Among authors: ho cys. Cancers (Basel). 2024 Jul 15;16(14):2547. doi: 10.3390/cancers16142547. Cancers (Basel). 2024. PMID: 39061189 Free PMC article.

9

Mutation Spectrum Comparison between Benign Breast Lesion Cohort, Unselected Cancer Cohort and High-Risk Breast Cancer Cohort.

Kwong A, Ho CYS, Leung HCM, Leung AWS, Au CH, Ma ESK. Kwong A, et al. Among authors: ho cys. Cancers (Basel). 2024 Sep 3;16(17):3066. doi: 10.3390/cancers16173066. Cancers (Basel). 2024. PMID: 39272924 Free PMC article.

10

Germline RAD51C and RAD51D Mutations in High-Risk Chinese Breast and/or Ovarian Cancer Patients and Families.

Kwong A, Ho CYS, Au CH, Tey SK, Ma ESK. Kwong A, et al. Among authors: ho cys. J Pers Med. 2024 Aug 16;14(8):866. doi: 10.3390/jpm14080866. J Pers Med. 2024. PMID: 39202057 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

18 results

Search Page

Filters